Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Mineralys Therapeutics, Inc.(MLYS) | 8,903,838 | 8,903,838 | 0 | 120,469 | 337,634 | 96.09% | +217,165 |
| Phathom Pharmaceuticals, Inc.(PHAT) | 1,167,114 | 1,167,114 | 0 | 11,193 | 13,737 | 3.91% | +2,544 |